Stay updated on Inhaled sGC Stimulator in PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled sGC Stimulator in PAH Clinical Trial page.

Latest updates to the Inhaled sGC Stimulator in PAH Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check34 days agoChange DetectedThe page has been updated to reflect a new version of a clinical study on Frespaciguat (MK-5475) for pulmonary arterial hypertension, with the latest revision dated May 25, 2025, replacing the previous version from February 21, 2025.SummaryDifference15%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check77 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check84 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 21, 2025.SummaryDifference1.0%
Stay in the know with updates to Inhaled sGC Stimulator in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled sGC Stimulator in PAH Clinical Trial page.